Takeda

Teva’s Parkinson Drug Now Marketed in Japan

By Anav Silverman, Tazpit News Agency

Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.